Biotransformation of Timosaponin BII into Seven Characteristic Metabolites by the Gut Microbiota

Timosaponin BII is one of the most abundant Anemarrhena saponins and is in a phase II clinical trial for the treatment of dementia. However, the pharmacological activity of timosaponin BII does not match its low bioavailability. In this study, we aimed to determine the effects of gut microbiota on t...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Guo-Ming, Yu, Hang, Pan, Li-Bin, Ma, Shu-Rong, Xu, Hui, Zhang, Zheng-Wei, Han, Pei, Fu, Jie, Yang, Xin-Yu, Keranmu, Adili, Niu, Hai-Tao, Jiang, Jian-Dong, Wang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270264/
https://www.ncbi.nlm.nih.gov/pubmed/34202717
http://dx.doi.org/10.3390/molecules26133861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270264/
https://www.ncbi.nlm.nih.gov/pubmed/34202717
http://dx.doi.org/10.3390/molecules26133861

Ejemplares similares